AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,462,000 | -99.8% | 860,000 | 0.0% | 4.73% | +89.3% |
| Q3 2019 | $24,157,400,000 | -33.9% | 860,000 | -10.9% | 2.50% | -26.9% |
| Q2 2019 | $36,534,900,000 | +92604.6% | 965,000 | -4.5% | 3.42% | -21.0% |
| Q1 2019 | $39,410,000 | +114.9% | 1,010,000 | +17.4% | 4.33% | +38.0% |
| Q4 2018 | $18,335,000 | -25.9% | 860,000 | +37.6% | 3.14% | +4.3% |
| Q3 2018 | $24,744,000 | +43.9% | 625,000 | +38.9% | 3.01% | +25.0% |
| Q2 2018 | $17,195,000 | +27.2% | 450,000 | 0.0% | 2.40% | +1.1% |
| Q1 2018 | $13,523,000 | +8.2% | 450,000 | +12.5% | 2.38% | -21.9% |
| Q4 2017 | $12,500,000 | +11.6% | 400,000 | 0.0% | 3.04% | -3.8% |
| Q3 2017 | $11,204,000 | +46.4% | 400,000 | 0.0% | 3.16% | +11.8% |
| Q2 2017 | $7,652,000 | +72.7% | 400,000 | +53.8% | 2.83% | +8.3% |
| Q1 2017 | $4,430,000 | – | 260,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |